This article reviews the cumulative data on @entity2099 which are the result of ovulation induction. Generally, those @entity1 who require ovulation induction fall into 2 groups--those with primary or secondary @entity2588 , low levels of endogenous gonadotropins, and lack of endogenous @entity172 activity, and those with @entity3206 due to @entity1866 who have evidence of endogenous @entity172 activity. The various ovulation-inducing preparations are discussed and they include gonadotropins ([hPG] @entity1 pituitary gonadotropin and [hMG] @entity1 menopausal gonadotropin), @entity4082 , and agents which inhibit prolactin secretion. A variety of treatment schedules for gonadotropin administration have been advised and nearly all are based on the fact that hPG and hMG result in follicular growth and maturation and that ovulation can be induced by a triggering dose of hCG. A nonoverlapping regimen results in a significantly lower incidence of @entity2099 . @entity4082 administration must be varied according to the individual @entity1 . Various combination therapies exist such as @entity4082 and hMG or hPG or @entity2847 and @entity4082 or Parlodel and pergonal or LH-RH. Early diagnosis of @entity2099 is important since it enables the early institution of therapeutic measures which are likely to prevent maternal complications. Among the diagnostic methods are clinical examination, ultrasonography, radiography, and determinations of biochemical parameters. These @entity2099 can result in maternal complications and its effects on the fetus can be serious as well. @entity2208 , @entity3465 , perinatal mortality, and @entity600 are some of the complications which can occur. There are attempts being made to reduce the incidence of multiple births by monitoring @entity172 , monitoring follicular diameter measurements, selecting appropriate @entity1 for therapy, and choosing a suitable regimen of treatment. Common measures taken in the management of multiple pregnancy include bed rest, myometrial relaxants, and suturing of the cervix.

XXXX following induction of ovulation.

@entity1 :: ('9606', 'Species') :: ['human', 'patients', 'patient'] @entity172 :: ('MESH:D004967', 'Chemical') :: ['estrogen', 'estrogens'] @entity2847 :: ('MESH:D001971', 'Chemical') :: ['Parlodel'] @entity2208 :: ('MESH:D000022', 'Disease') :: ['Spontaneous abortion'] @entity3465 :: ('MESH:C536271', 'Disease') :: ['premature delivery'] @entity4082 :: ('MESH:D002996', 'Chemical') :: ['Clomiphene', 'clomiphene'] @entity3206 :: ('MESH:D000858', 'Disease') :: ['anovulation'] @entity600 :: ('MESH:D000014', 'Disease') :: ['congenital malformations'] @entity1866 :: ('MESH:D008599', 'Disease') :: ['menstrual disorders'] @entity2099 :: ('MESH:D011254', 'Disease') :: ['multiple pregnancies'] @entity2588 :: ('MESH:D000568', 'Disease') :: ['amenorrhea']
@entity2099 :: (MESH:D011254,Disease) :: ['Multiple pregnancies']
